A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Penumbra Inc stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 45 shares of PEN stock, worth $10,702. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Previous 108 58.33%
Holding current value
$10,702
Previous $24,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$172.27 - $223.95 $10,853 - $14,108
-63 Reduced 58.33%
45 $8,000
Q1 2024

Apr 29, 2024

BUY
$220.09 - $273.15 $440 - $546
2 Added 1.89%
108 $24,000
Q4 2023

Feb 06, 2024

BUY
$181.44 - $260.22 $12,156 - $17,434
67 Added 171.79%
106 $27,000
Q4 2022

Feb 07, 2023

SELL
$151.88 - $228.5 $8,201 - $12,339
-54 Reduced 58.06%
39 $9,000
Q2 2022

Aug 12, 2022

BUY
$116.09 - $227.33 $8,474 - $16,595
73 Added 365.0%
93 $12,000
Q1 2019

May 15, 2019

BUY
$115.84 - $160.31 $2,316 - $3,206
20 New
20 $3,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.01B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Benjamin F. Edwards & Company, Inc. Portfolio

Follow Benjamin F. Edwards & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.